Literature DB >> 27506794

RNF122 suppresses antiviral type I interferon production by targeting RIG-I CARDs to mediate RIG-I degradation.

Wendie Wang1, Minghong Jiang1, Shuo Liu1, Shikun Zhang1, Wei Liu1, Yuanwu Ma2, Lianfeng Zhang2, Jiyan Zhang3, Xuetao Cao4.   

Abstract

The activation of retinoic acid-inducible gene 1 (RIG-I), a cytoplasmic innate sensor for viral RNA, is tightly regulated to maintain immune homeostasis properly and prevent excessive inflammatory reactions other than initiation of antiviral innate response to eliminate RNA virus effectively. Posttranslational modifications, particularly ubiquitination, are crucial for regulation of RIG-I activity. Increasing evidence suggests that E3 ligases play important roles in various cellular processes, including cell proliferation and antiviral innate signaling. Here we identify that E3 ubiquitin ligase RING finger protein 122 (RNF122) directly interacts with mouse RIG-I through MS screening of RIG-I-interacting proteins in RNA virus-infected cells. The transmembrane domain of RNF122 associates with the caspase activation and recruitment domains (CARDs) of RIG-I; this interaction effectively triggers RING finger domain of RNF122 to deliver the Lys-48-linked ubiquitin to the Lys115 and Lys146 residues of RIG-I CARDs and promotes RIG-I degradation, resulting in a marked inhibition of RIG-I downstream signaling. RNF122 is widely expressed in various immune cells, with preferential expression in macrophages. Deficiency of RNF122 selectively increases RIG-I-triggered production of type I IFNs and proinflammatory cytokines in macrophages. RNF122-deficient mice exhibit more resistance against lethal RNA virus infection, with increased production of type I IFNs. Thus, we demonstrate that RNF122 acts as a selective negative regulator of RIG-I-triggered antiviral innate response by targeting CARDs of RIG-I and mediating proteasomal degradation of RIG-I. Our study outlines a way for E3 ligase to regulate innate sensor RIG-I for the control of antiviral innate immunity.

Entities:  

Keywords:  E3 ligase; RIG-I; RNF122; innate immunity; type I interferon

Mesh:

Substances:

Year:  2016        PMID: 27506794      PMCID: PMC5003265          DOI: 10.1073/pnas.1604277113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

Review 1.  Pattern recognition receptors and inflammation.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection.

Authors:  Hiroyuki Oshiumi; Moeko Miyashita; Naokazu Inoue; Masaru Okabe; Misako Matsumoto; Tsukasa Seya
Journal:  Cell Host Microbe       Date:  2010-12-16       Impact factor: 21.023

3.  Molecular mechanisms of coupled monoubiquitination.

Authors:  Tanja Woelk; Barbara Oldrini; Elena Maspero; Stefano Confalonieri; Elena Cavallaro; Pier Paolo Di Fiore; Simona Polo
Journal:  Nat Cell Biol       Date:  2006-10-01       Impact factor: 28.824

4.  Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3-mutant neoplasia.

Authors:  Bon-Kyoung Koo; Johan H van Es; Maaike van den Born; Hans Clevers
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-28       Impact factor: 11.205

5.  RIGorous detection: exposing virus through RNA sensing.

Authors:  Jan Rehwinkel; Caetano Reis e Sousa
Journal:  Science       Date:  2010-01-15       Impact factor: 47.728

6.  The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.

Authors:  Alessandro Sorrentino; Noopur Thakur; Susanne Grimsby; Anders Marcusson; Verena von Bulow; Norbert Schuster; Shouting Zhang; Carl-Henrik Heldin; Maréne Landström
Journal:  Nat Cell Biol       Date:  2008-08-31       Impact factor: 28.824

Review 7.  Type I interferon dysregulation and neurological disease.

Authors:  Sarah McGlasson; Alexa Jury; Andrew Jackson; David Hunt
Journal:  Nat Rev Neurol       Date:  2015-08-25       Impact factor: 42.937

8.  RNF122: a novel ubiquitin ligase associated with calcium-modulating cyclophilin ligand.

Authors:  Zhi Peng; Taiping Shi; Dalong Ma
Journal:  BMC Cell Biol       Date:  2010-06-17       Impact factor: 4.241

9.  E3 ubiquitin ligase CHIP facilitates Toll-like receptor signaling by recruiting and polyubiquitinating Src and atypical PKC{zeta}.

Authors:  Mingjin Yang; Chen Wang; Xuhui Zhu; Songqing Tang; Liyun Shi; Xuetao Cao; Taoyong Chen
Journal:  J Exp Med       Date:  2011-09-12       Impact factor: 14.307

Review 10.  Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins.

Authors:  Taro Kawai; Shizuo Akira
Journal:  EMBO Mol Med       Date:  2011-08-09       Impact factor: 12.137

View more
  41 in total

Review 1.  Cellular and molecular regulation of innate inflammatory responses.

Authors:  Juan Liu; Xuetao Cao
Journal:  Cell Mol Immunol       Date:  2016-10-31       Impact factor: 11.530

2.  DAMP-driven metabolic adaptation.

Authors:  Kirsty Minton
Journal:  Nat Rev Immunol       Date:  2020-01       Impact factor: 53.106

3.  Long noncoding RNA: TRIMming the viral load.

Authors:  Akhilesh Kumar; Himanshu Kumar
Journal:  Cell Mol Immunol       Date:  2019-09-11       Impact factor: 11.530

Review 4.  Negative regulators of the RIG-I-like receptor signaling pathway.

Authors:  Kendra M Quicke; Michael S Diamond; Mehul S Suthar
Journal:  Eur J Immunol       Date:  2017-04       Impact factor: 5.532

Review 5.  Post-Translational Modifications of Proteins in Cytosolic Nucleic Acid Sensing Signaling Pathways.

Authors:  Yu Deng; Ying Wang; Lupeng Li; Edward A Miao; Pengda Liu
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

Review 6.  Regulation of cGAS- and RLR-mediated immunity to nucleic acids.

Authors:  Andrea Ablasser; Sun Hur
Journal:  Nat Immunol       Date:  2019-12-09       Impact factor: 25.606

Review 7.  Post-translational Control of Intracellular Pathogen Sensing Pathways.

Authors:  Cindy Chiang; Michaela U Gack
Journal:  Trends Immunol       Date:  2016-11-15       Impact factor: 16.687

8.  "Toll-free" pathways for production of type I interferons.

Authors:  Ling Wang; Shunbin Ning
Journal:  AIMS Allergy Immunol       Date:  2017-11-06

9.  MLL5 suppresses antiviral innate immune response by facilitating STUB1-mediated RIG-I degradation.

Authors:  Peipei Zhou; Xiaodan Ding; Xiaoling Wan; Lulu Liu; Xiujie Yuan; Wei Zhang; Xinhui Hui; Guangxun Meng; Hui Xiao; Bin Li; Jin Zhong; Fajian Hou; Lihwen Deng; Yan Zhang
Journal:  Nat Commun       Date:  2018-03-28       Impact factor: 14.919

10.  Ubiquitination and degradation of NF90 by Tim-3 inhibits antiviral innate immunity.

Authors:  Shuaijie Dou; Guoxian Li; Ge Li; Chunmei Hou; Yang Zheng; Lili Tang; Yang Gao; Rongliang Mo; Yuxiang Li; Renxi Wang; Beifen Shen; Jun Zhang; Gencheng Han
Journal:  Elife       Date:  2021-06-10       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.